454
J . Org. Chem. 1997, 62, 454-455
Sch em e 1a
En a n tioselective Syn th esis of th e
Ela iop h ylin Aglycon
David A. Evans* and Duke M. Fitch
Department of Chemistry & Chemical Biology,
Harvard University, Cambridge, Massachusetts 02138
Received November 26, 1996
Elaiophylin (1) was isolated in 1959 by Arcamone and
co-workers from cultures of Streptomyces melanosporus.1
Subsequently, this natural product has also been ob-
tained from other strains of Streptomyces.2 Structure
elucidation of 1, including assignment of absolute ster-
eochemistry, was based on chemical degradation,3 NMR
studies,4 and ultimately X-ray crystallographic analysis.5
Isolation and characterization of the elaiophylin aglycon,
elaiolide (2), was accomplished by Zeeck and Bindseil in
1993 through deglycosylation of 1.6
a
Key: (a) LDA, THF; EtI, -78 °C; (b) 2,6-lutidine, TBSOTf,
CH2Cl2, 0 °C; (c) DIBAl-H, CH2Cl2, -78 to -40 °C; (d) oxalyl
chloride, DMSO, CH2Cl2; Et3N, -78 °C; (e) BF3‚OEt2, CH2Cl2, -78
°C; (f) TBAF, THF, 25 °C; (g) 2,6-lutidine, (t-Bu)2Si(OTf)2, CH2Cl2,
0 °C; (h) O3, 3:1 CH2Cl2/MeOH, -78 °C; Me2S.
Sch em e 2a
a
Key: (a) n-Bu2BOTf, Et3N, 0 °C; methacrolein, CH2Cl2, -78
°C; H2O2; (b) 2,6-lutidine, TESOTf, CH2Cl2, 0 °C; (c) LiBH4, Et2O,
H2O, 25 °C; (d) TrCl, Et3N, DMAP, CH2Cl2; (e) 9-BBN dimer, THF,
0 °C; H2O2; (f) oxalyl chloride, DMSO, CH2Cl2; Et3N, -78 °C; (g)
LiHMDS, triethyl 4-phosphonocrotonate, THF, -78 °C; 11; (h)
HF‚pyr., THF, 0 °C.
As a result of its structural complexity and potent
biological activity,7 elaiophylin has been a target of
considerable synthetic interest. The first synthesis of
elaiophylin was accomplished by Kinoshita and co-
workers in 1986.8 In the previous year, Seebach and co-
workers reported the synthesis of an aglycon derivative
originally obtained from the acidic methanolysis of elaio-
phylin,9 which was later identified as 11,13,11′,13′-tetra-
O-methylelaiolide (3).6 Several other studies directed
toward the synthesis of the elaiophylin framework have
also been published.10,11 The common fragment coupling
strategy in the majority of these syntheses has been the
double stereodifferentiating aldol bond construction of the
C9-C10 bond (eq 1).11 This aldol assemblage strategy
carries the inherent liability that any lack of selectivity
in the aldol process is magnified over two reaction sites,
producing a complex mixture of isomers. In both the
Kinoshita and Seebach syntheses, this problem resulted
in isolation of the desired aldol adduct as the minor
product diastereomer in low yield.
Recent studies from this laboratory concerned with the
synthesis of bafilomycin A1 have revealed a strategy for
rendering these types of aldol bond constructions highly
diastereoselective.12 In this investigation, it was found
that high aldol diastereoselectivity could be obtained by
restricting the conformational flexibility of the ketone
through the use of a linking cyclic protecting group for
the C13 and C15 hydroxyl groups in conjunction with the
use of an electronically altered phenylchloroboryl eno-
late.13 An application of this successful strategy to the
synthesis of elaiolide (2) is described below.
(1) Arcamone, F. M.; Bertazzoli, C.; Ghione, M.; Scotti, T. G.
Microbiol. 1959, 7, 207.
(2) (a) Azalomycin B: Arai, M. J . Antibiot. Ser. A 1960, 13, 46, 51.
(b) Antibiotic 225 E: Khlebarova, E. I.; Georgieva-Borisova, I. K.;
Sheikova, G. N.; Blinov, N. O. Farmatsiya (Sofia) 1972, 22, 3. (c)
Salbomycin: Hoechst Patent DE 3248-280-A, 1972.
(3) (a) Takahashi, S.; Arai, M.; Ohki, E. Chem. Pharm. Bull. 1967,
15, 1651. (b) Takahashi, S.; Kurabayashi, M.; Ohki, E. Chem. Pharm.
Bull. 1967, 15, 1657. (c) Takahashi, S.; Ohki, E. Chem. Pharm. Bull.
1967, 15, 1726.
(4) Kaiser, H.; Keller-Scheirlein, W. Helv. Chim. Acta 1981, 64, 407.
(5) Neupert-Laves, K.; Dobler, M. Helv. Chim. Acta 1982, 65, 262.
(6) Bindseil, K. U.; Zeeck, A. J . Org. Chem. 1993, 58, 5487.
(7) (a) Omura, S. Macrolide Antibiotics: Chemistry, Biology, and
Practice; Academic Press: New York, 1984. (b) Liu, C.-M.; J ensen, L.;
Westley, J . W.; Siegel, D. J . Antibiot. 1993, 46, 350.
(8) (a) Toshima, K.; Tatsuta, K.; Kinoshita, M. Tetrahedron Lett.
1986, 27, 4741. (b) Toshima, K.; Tatsuta, K.; Kinoshita, M. Bull. Chem.
Soc. J pn. 1988, 61, 2369.
(9) (a) Seebach, D.; Chow, H.-F.; J ackson, R. F. W.; Sutter, M. A.;
Thaisrivongs, S.; Zimmerman, J . Liebigs Ann. Chem. 1986, 1281. (b)
Seebach, D.; Chow, H.-F.; J ackson, R. F. W.; Lawson, K.; Sutter, M.
A.; Thaisrivongs, S.; Zimmerman, J . J . Am. Chem. Soc. 1985, 107, 5292.
(10) (a) Wakamatsu, T.; Nakamura, H.; Nara, E.; Ban, Y. Tetrahe-
dron Lett. 1986, 27, 3895. (b) Wakamatsu, T.; Yamada, S.; Nakamura,
H.; Ban, Y. Heterocycles 1987, 25, 43. (c) Formal total synthesis of
elaiophylin: Nakamura, H.; Arata, K., Wakamatsu, T.; Ban, Y.;
Shibasaki, M. Chem. Pharm. Bull. 1990, 38, 2435.
(11) A notable exception is the approach of Ziegler and co-workers,
which involves the design of a fully elaborated monomeric fragment
suitable for dimerization: Ziegler, F. E.; Tung, J . S. J . Org. Chem.
1991, 56, 6530.
Synthesis of ethyl ketone 8 began with the R-ethylation
of 4 according to the Seebach procedure9a to afford the
(12) (a) Evans, D. A.; Calter, M. A. Tetrahedron Lett. 1993, 34, 6871.
(b) Calter, M. A. Ph.D. Dissertation, Harvard University, 1993. (c) This
same aldol reaction has been subsequently employed by Toshima and
co-workers in their synthesis of bafilomycin A1. Toshima, K.; Yamagu-
chi, H.; J yojima, T.; Noguchi, Y.; Nakata, M.; Matsumura, S. Tetra-
hedron Lett. 1996, 37, 1073.
S0022-3263(96)02188-3 CCC: $14.00 © 1997 American Chemical Society